MVASI
NDC 55513-207, bevacizumab-awwb, injection, solution, from Amgen, Inc.
- Product NDC
- 55513-207
- Status
- Listed
- Labeler
- Amgen, Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761028
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-207 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BEVACIZUMAB400 mg/16mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]; Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-207-01 | 55513020701 | 1 VIAL in 1 CARTON (55513-207-01) / 16 mL in 1 VIAL |
| 55513-207-21 | 55513020721 | 1 VIAL in 1 CARTON (55513-207-21) / 16 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0a562b4e-67ce-4bab-852c-d9ee71e55fb8Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55513-207
Use it
Look up 55513-207 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-207 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-207. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.